Dadan, Vryll Jazzer I.

HRN: 11-80-52  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/04/2023
CEFUROXIME 750MG (VIAL)
06/04/2023
06/11/2023
IV
500mg
Q8hrs
PCAP-C
Waiting Final Action 
06/04/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
06/04/2023
06/10/2023
IV
2.25grams
Q8hr
Pneumonia
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: